NCT00163098已完成1 期
A Multi-Centre, Multinational, Randomized, Double-Blind, Placebo Controlled, Proof Of Concept Trial To Assess The Effects Of A Subject-Optimized Dose Of UK-369,003 On Exercise Capacity In Subjects With Chronic Obstructive Pulmonary Disease
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- Pfizer
- 入组人数
- 136
- 试验地点
- 28
- 主要终点
- Effect on exercise tolerance
研究概览
简要总结
A randomised, controlled study investigating the effect of UK-369,003 on exercise tolerance in patients with COPD
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 35 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •GOLD criteria 2 to 4
- •10 pack year history of smoking
排除标准
- •Women of child bearing potential
结局指标
主要结局
Effect on exercise tolerance
次要结局
- Effect on lung function and quality of life
研究者
研究点 (28)
Loading locations...
相似试验
已完成
3 期
An Exercise Endurance Study to Evaluate the Effects of Treatment of Chronic Obstructive Pulmonary Disease (COPD) Patients With a Dual Bronchodilator: GSK573719/GW642444. Study APulmonary Disease, Chronic ObstructiveNCT01328444GlaxoSmithKline349
已完成
3 期
An Exercise Endurance Study to Evaluate the Effects of Treatment of Chronic Obstructive Pulmonary Disease (COPD) Patients With a Dual Bronchodilator: GSK573719/GW642444.Study BPulmonary Disease, Chronic ObstructiveNCT01323660GlaxoSmithKline307
已完成
2 期
Effect of the Rehabilitation Effort at Home in Patients With Head and Neck Tumor Treated With Curative IntentHead and Neck CancerNCT02135185Institut du Cancer de Montpellier - Val d'Aurelle70
已完成
不适用
Benefits and Tolerance of Exercise in Patients With Generalized and Stabilized Myasthenia GravisMyasthenia GravisNCT02066519Assistance Publique - Hôpitaux de Paris45
已完成
3 期
Effect of Treatment BI 1744 CL (5 and 10 mcg) Versus Placebo on Exercise Endurance Time During Constant Work Rate Cycle Ergometry IPulmonary Disease, Chronic ObstructiveNCT01040130Boehringer Ingelheim151